A proven leader who brings her creativity and extensive business development, financial management, and administrative experience to the drug development process. She has been integral in business and program commercialization for several large scale, system-wide medical center service expansion & corporate reorganization. Over 25 years as CEO in practice, founding four companies including CBT. She oversees fundraising and operations for CBT.

An innovative investigational biochemist, he has moved 4 therapies from the bench to clinical trials and 2 to market at Abbott/AbbVie. He has been a leader in the fields of thrombolytics and cancer/angiogenesis with several patents, publications and 2 NSF SBIR awards. He is able to integrate a breadth of information easily looking past known science to the next level and beyond to identify pathways used for cancer survival and drug resistance.

Decisive, visionary leader and senior level pharmaceutical industry executive specializing in strategic planning, best practices, & building high performing teams. Over 30 years experience growing key pharmaceutical brands through best-in-class strategy and commercial analytics. Significant experience in small start-ups and large organizations. Proven success in strategic positioning for multi-billion dollar products in demanding environments.

Results oriented professional with executive-level expertise in quality, clinical development & inspection administration. Recognized leader building relationships to maximize collective skills across functional groups. Direct global, multi-disciplinary teams achieving corporate goals. Extensive experience in highly regulated, rapidly changing business including pharmaceutical, pharmacovigilance, vendor/staff management and risk management.